Shen, L.; Xi, M.; Zhao, L.; Zhang, X.; Wang, X.; Huang, Z.; Chen, Q.; Zhang, T.; Shen, J.; Liu, M.;
et al. Combination Therapy after TACE for Hepatocellular Carcinoma with Macroscopic Vascular Invasion: Stereotactic Body Radiotherapy versus Sorafenib. Cancers 2018, 10, 516.
https://doi.org/10.3390/cancers10120516
AMA Style
Shen L, Xi M, Zhao L, Zhang X, Wang X, Huang Z, Chen Q, Zhang T, Shen J, Liu M,
et al. Combination Therapy after TACE for Hepatocellular Carcinoma with Macroscopic Vascular Invasion: Stereotactic Body Radiotherapy versus Sorafenib. Cancers. 2018; 10(12):516.
https://doi.org/10.3390/cancers10120516
Chicago/Turabian Style
Shen, Lujun, Mian Xi, Lei Zhao, Xuhui Zhang, Xiuchen Wang, Zhimei Huang, Qifeng Chen, Tianqi Zhang, Jingxian Shen, Mengzhong Liu,
and et al. 2018. "Combination Therapy after TACE for Hepatocellular Carcinoma with Macroscopic Vascular Invasion: Stereotactic Body Radiotherapy versus Sorafenib" Cancers 10, no. 12: 516.
https://doi.org/10.3390/cancers10120516
APA Style
Shen, L., Xi, M., Zhao, L., Zhang, X., Wang, X., Huang, Z., Chen, Q., Zhang, T., Shen, J., Liu, M., & Huang, J.
(2018). Combination Therapy after TACE for Hepatocellular Carcinoma with Macroscopic Vascular Invasion: Stereotactic Body Radiotherapy versus Sorafenib. Cancers, 10(12), 516.
https://doi.org/10.3390/cancers10120516